Analysis of the cost‐effectiveness of proton beam therapy for unresectable pancreatic cancer in Japan

Analysis of the cost‐effectiveness of proton beam therapy for unresectable pancreatic cancer in Japan

Abstract Background Proton beam therapy (PBT) has recently been included in Japan's social health insurance benefits package. This study aimed to determine the cost‐effectiveness of PBT for unresectable, locally advanced pancreatic cancer (LAPC) as a replacement for conventional photon radiothe...

Full description

Bibliographic Details
Main Authors:	Yuichi Hiroshima, Masahide Kondo, Takuya Sawada, Shu‐ling Hoshi, Reiko Okubo, Takashi Iizumi, Haruko Numajiri, Toshiyuki Okumura, Hideyuki Sakurai
Format:	Article
Language:	English
Published:	Wiley 2023-10-01
Series:	Cancer Medicine
Subjects:	chemoradiotherapy cost‐effectiveness incremental cost‐effectiveness ratio locally advanced pancreatic cancer particle radiotherapy proton beam therapy
Online Access:	https://doi.org/10.1002/cam4.6611

Similar Items

Long-term follow up of a patient with a recurrent desmoid tumor that was successfully treated with proton beam therapy: A case report and literature review
by: Takuya Sawada, et al.
Published: (2021-03-01)

An Analysis of Vertebral Body Growth after Proton Beam Therapy for Pediatric Cancer
by: Keiichiro Baba, et al.
Published: (2021-01-01)

Universal Dental Adhesives: Cost-Effectiveness and Duration of Use
by: Ayman A. Banjar, et al.
Published: (2022-01-01)

Proton beam therapy for a giant hepatic hemangioma: A case report and literature review
by: Shosei Shimizu, et al.
Published: (2021-03-01)

Proton pump inhibitors: potential cost reductions by applying prescribing guidelines
by: Cahir Caitriona, et al.
Published: (2012-11-01)

Clinical outcomes of previously untreated patients with unresectable intrahepatic cholangiocarcinoma following proton beam therapy
by: Shosei Shimizu, et al.
Published: (2019-12-01)

Cost-effectiveness of treatment in adults with blood pressure of 130–139/80–89 mmHg and high cardiovascular risk in China: a modelling studyResearch in context
by: Jiangtao Li, et al.
Published: (2024-01-01)

Transitions of Liver and Biliary Enzymes during Proton Beam Therapy for Hepatocellular Carcinoma
by: Taisuke Sumiya, et al.
Published: (2020-07-01)

Intensive care unit mortality and cost-effectiveness associated with intensivist staffing: a Japanese nationwide observational study
by: Saori Ikumi, et al.
Published: (2023-12-01)

How reliable are ICER’s results published in current pharmacoeconomic literature? The controversial issue of price confidentiality
by: Pierluigi Russo
Published: (2022-02-01)

Cost–Effectiveness Analysis of Pharmacist Adherence Interventions in People Living with HIV/AIDS in Pakistan
by: Ali Ahmed, et al.
Published: (2023-09-01)

Cost-effectiveness of fluocinolone acetonide implant (ILUVIEN®) in UK patients with chronic diabetic macular oedema considered insufficiently responsive to available therapies
by: Michal Pochopien, et al.
Published: (2019-01-01)

Efficacy and cost‐effectiveness analysis of pretreatment percutaneous endoscopic gastrostomy in unresectable locally advanced esophageal cancer patients treated with concurrent chemoradiotherapy (GASTO 1059)
by: XinLei Ai, et al.
Published: (2023-07-01)

Proton pump inhibitors overuse: only inappropriate prescriptions or further iatrogenic damage?
by: Mario Visconti
Published: (2015-09-01)

Acute toxicity and patient‐reported symptom score after conventional versus moderately hypofractionated proton therapy for prostate cancer
by: Takashi Iizumi, et al.
Published: (2022-06-01)

Cost-Effectiveness of Canagliflozin Versus Dapagliflozin Added to Metformin in Patients With Type 2 Diabetes in China
by: Xingyun Hou, et al.
Published: (2019-05-01)

Cost-effectiveness and feasibility of conditional economic incentives and motivational interviewing to improve HIV health outcomes of adolescents living with HIV in Anambra State, Nigeria
by: Obinna Ikechukwu Ekwunife, et al.
Published: (2021-07-01)

Individualized quality of life benefit and cost-effectiveness estimates of proton therapy for patients with oropharyngeal cancer
by: N. Patrik Brodin, et al.
Published: (2021-01-01)

Cost-effectiveness of the Perioperative Pain Management Bundle a registry-based study
by: Suzana Bojic, et al.
Published: (2023-09-01)

Cost‐utility analysis of add‐on dapagliflozin in heart failure with reduced ejection fraction in the Philippines
by: Victor L. Mendoza, et al.
Published: (2021-12-01)

Cost-Effectiveness Analysis of Chemoradiation and Radiotherapy Treatment for Stage IIB and IIIB Cervical Cancer Patients
by: Puspitasari IM, et al.
Published: (2021-02-01)

Proton Therapy: Ever Shifting Sands and the Opportunities and Obligations Within
by: Christine E Hill-Kayser, et al.
Published: (2011-09-01)

Economic evaluation of routine infant rotavirus immunisation program in Japan
by: Shu-ling Hoshi, et al.
Published: (2017-05-01)

Cost-Effectiveness of Secukinumab Versus Other Biologics in the Treatment of Moderate-to-Severe Plaque Psoriasis: The Chinese Healthcare System Perspective
by: Jinsui Zhang, et al.
Published: (2023-09-01)

Commentary: Beyond 10-year risk: A cost-effectiveness analysis of statins for the primary prevention of cardiovascular disease
by: Aditya Shah, et al.
Published: (2022-07-01)

Cost-utility analysis of total knee arthroplasty alone and in comparison with post-surgical rehabilitation and conservative treatment in the Republic of Kazakhstan
by: Dinara Serikova-Esengeldina, et al.
Published: (2022-09-01)

Individualised selection of left‐sided breast cancer patients for proton therapy based on cost‐effectiveness
by: Annabelle M. Austin, et al.
Published: (2021-03-01)

Proton beam therapy for a patient with a giant thymic carcinoid tumor and severe superior vena cava syndrome
by: Kaori Sugawara, et al.
Published: (2014-05-01)

Cost-effectiveness of robotic-assisted spinal surgery: A single-center retrospective study
by: Sorayouth Chumnanvej, et al.
Published: (2023-12-01)

Cost-effectiveness of Tele-delivered behavioral activation by Lay counselors for homebound older adults with depression
by: Guoqing John Chen, et al.
Published: (2022-10-01)

A comparison of small monetary incentives to convert survey non-respondents: a randomized control trial
by: Grill Joseph P, et al.
Published: (2011-05-01)

Cost-effectiveness analysis of secukinumab versus other biologics and apremilast in the treatment of active Psoriatic arthritis: a Finnish perspective
by: Timo Purmonen, et al.
Published: (2018-11-01)

Preliminary results of proton radiotherapy for pediatric rhabdomyosarcoma: a multi‐institutional study in Japan
by: Masashi Mizumoto, et al.
Published: (2018-05-01)

Modelling the cost-effectiveness of mass screening and treatment for reducing <it>Plasmodium falciparum</it> malaria burden
by: Crowell Valerie, et al.
Published: (2013-01-01)

How to assess the value of medicines?
by: Steven Simoens
Published: (2010-09-01)

Light flash and odor during proton beam therapy for pediatric patients: a prospective observational study
by: Masashi Mizumoto, et al.
Published: (2022-08-01)

Lutetium oxodotreotide (177Lu-Dotatate) for the treatment of unresectable or metastatic progressive gastroenteropancreatic neuroendocrine tumors: a cost-effectiveness analysis for Scotland
by: J. Smith-Palmer, et al.
Published: (2021-01-01)

Cost-effectiveness and budget impact analysis of screening and preventive interventions for cardiovascular disease in Myanmar: an economic modelling studyResearch in context
by: Zin Mar Win, et al.
Published: (2024-07-01)

Cost-effectiveness analysis of first-line tislelizumab plus chemotherapy for recurrent or metastatic nasopharyngeal cancer
by: Zhengda Pei, et al.
Published: (2023-10-01)

The effect of medical innovation on the cost-effectiveness of Covid 19-related policies in the United States using a SIR model
by: Adam J. Atherly, et al.
Published: (2023-04-01)